Bio-pharm, Inc.

FDA Regulatory Profile

Bio-pharm, Inc. appears in FDA public data with 2 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0809-2016, Class III) was initiated on December 17, 2015.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Known Names

bio-pharm, biopharm

Recent Recalls

NumberClassProductDate
D-0809-2016Class IIIRanitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5 mL), 16 fl oz Bottle, Rx only, MDecember 17, 2015
D-0028-2015Class IIRugby Children's Pain and Fever Acetaminophen Oral Suspension 160 mg/5 mL, Cherry Flavor, 2 FL. oz bJuly 16, 2014